Clinical Trial Update: A Study to Assess the Antibody Response of Healthy Chinese Children Who Have Been Vaccinated Previously With 4-doses of Prevenar (a Pneumococcal Vaccine) as Babies and Toddlers [Phase 4]

View source ↗

Summary

Phase 4 trial updating antibody response in healthy Chinese children previously vaccinated with Prevenar as infants, assessing long-term immune response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Prevenar (pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Pneumococcal Disease | Phase 4 | Status: COMPLETED | Results posted: 2012-03-16